AI Article Synopsis
- Cancer and its treatment can lead to severe symptoms that lower patients' quality of life and increase their need for healthcare services and hospital stays.* -
- The IMPACT Consortium aims to create and test systematic approaches for better symptom management using electronic health record systems.* -
- The framework and organizational structure of the IMPACT Consortium are described, along with insights on study design and challenges faced during the COVID-19 pandemic.*
Article Abstract
Cancer and its treatment produce deleterious symptoms across the phases of care. Poorly controlled symptoms negatively affect quality of life and result in increased health-care needs and hospitalization. The Improving the Management of symPtoms during And following Cancer Treatment (IMPACT) Consortium was created to develop 3 large-scale, systematic symptom management systems, deployed through electronic health record platforms, and to test them in pragmatic, randomized, hybrid effectiveness and implementation trials. Here, we describe the IMPACT Consortium's conceptual framework, its organizational components, and plans for evaluation. The study designs and lessons learned are highlighted in the context of disruptions related to the COVID-19 pandemic.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627528 | PMC |
| http://dx.doi.org/10.1093/jncics/pkad073 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!